A large fraction of patients with diabetes mellitus require insulin treatment to control glucose metabolism; however, this treatment brings risks of hypoglycaemia and provides suboptimal metabolic control. Transplantation of stem cell-derived pancreatic islet cells could be an ideal solution, which is approaching clinical translation.
This is a preview of subscription content, log in via an institution to check access.
References
National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America 3rd ed (NIH, 2018).
Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L. & Millman, J. R. Single-cell transcriptome profiling reveals beta cell maturation in stem cell-derived islets after transplantation. Cell Rep. 32, 108067 (2020).
Ricordi, C. et al. National Institutes of Health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities. Diabetes 65, 3418–3428 (2016).
Lablanche, S. et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 6, 527–537 (2018).
Ricordi, C. et al. Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.? CellR4 7, e2768 (2019).
D’Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006).
Pagliuca, F. W. et al. Generation of functional human pancreatic beta cells in vitro. Cell 159, 428–439 (2014).
Velazco-Cruz, L. et al. Acquisition of dynamic function in human stem cell-derived beta cells. Stem Cell Reports 12, 351–365 (2019).
Agulnick, A. D. et al. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med. 4, 1214–1222 (2015).
Millman, J. R. et al. Generation of stem cell-derived beta-cells from patients with type 1 diabetes. Nat. Commun. 7, 11463 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Lanzoni, G., Ricordi, C. Transplantation of stem cell-derived pancreatic islet cells. Nat Rev Endocrinol 17, 7–8 (2021). https://doi.org/10.1038/s41574-020-00430-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-020-00430-9
- Springer Nature Limited
This article is cited by
-
Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived β cells
BMC Genomics (2024)
-
Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin
Cell Death & Disease (2022)
-
Recapitulating pancreatic cell–cell interactions through bioengineering approaches: the momentous role of non-epithelial cells for diabetes cell therapy
Cellular and Molecular Life Sciences (2021)
-
Tissue Engineering Strategies for Improving Beta Cell Transplantation Outcome
Current Transplantation Reports (2021)